C-Rad AB (publ) (STO:CRAD.B)

Sweden flag Sweden · Delayed Price · Currency is SEK
32.35
+1.10 (3.52%)
At close: Dec 5, 2025
9.11%
Market Cap 1.05B
Revenue (ttm) 457.60M
Net Income (ttm) 23.25M
Shares Out 33.58M
EPS (ttm) 0.69
PE Ratio 45.48
Forward PE 14.91
Dividend n/a
Ex-Dividend Date n/a
Volume 17,350
Average Volume 68,998
Open 31.35
Previous Close 31.25
Day's Range 31.05 - 32.55
52-Week Range 26.05 - 37.40
Beta 0.95
RSI 47.95
Earnings Date Feb 12, 2026

About C-Rad AB

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Catalyst+ HD, a patient positioning, intra-fraction motion management, and respiratory gating solution for conventional and stereotactic treatment delivery; Catalyst+, a solution for patient set up and intra-fraction breath hold reproducibility; Catalyst+ PT, a surface image guided radiation therapy solution that supports pr... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2004
Employees 99
Stock Exchange Nasdaq Stockholm
Ticker Symbol CRAD.B
Full Company Profile

Financial Performance

In 2024, C-Rad AB's revenue was 469.00 million, an increase of 10.45% compared to the previous year's 424.62 million. Earnings were 56.45 million, an increase of 58.88%.

Financial Statements

News

C-Rad AB (FRA:24C) Q3 2025 Earnings Call Highlights: Strong Service Growth Amidst Regional ...

C-Rad AB (FRA:24C) Q3 2025 Earnings Call Highlights: Strong Service Growth Amidst Regional Challenges

6 weeks ago - GuruFocus